Key Clinical Summary: Detecting Subclinical Progression
This is a summary of Enduring Module presented by expert Barbara Burton, Professor Emeritus which you can find here:
Module 2: Detecting Subclinical Progression
Before participating, please read our CME and disclosure information which can be found in all of the links above.
This program is supported by an independent education grant from Amicus. This online education program has been designed for healthcare professionals in the US.
1. The Clinical Paradigm: Discordance as the Signal for Subclinical Progression
- Defining Subclinical Progression: In adults with Late-Onset Pompe Disease (LOPD) on long-term enzyme replacement therapy (ERT), active disease progression frequently occurs at the tissue and physiological level while primary motor performance appears stable.
- The Compensated Domain: Endurance metrics such as the Six-Minute Walk Test (6MWT) remain stable longest because patients unconsciously spend functional reserve through pacing, altered movement mechanics, and daily activity substitution. A stable 6MWT score does not rule out active disease progression.
- Multimodal Discordance: Subclinical progression is unmasked when objective worsening appears in structural imaging, respiratory mechanics, biochemical markers, or patient-reported outcomes (PROs) while motor endurance tests remain flat. Identifying discordance across complementary domains prevents misclassifying active deterioration as "treatment stability".
2. Domain-Specific Detection of Subclinical Deterioration
Structural Subclinical Progression (Quantitative Muscle MRI)
- Dixon Sequence Muscle Fat Fraction (FF): Chemical-shift quantitative MRI measures muscle fat replacement at the tissue level.
- Progressive Tissue Loss: In treated symptomatic LOPD, thigh muscle fat fraction increases at an average rate of approximately 1.9% per year.
- Structural-Functional Dissociation: Significant muscle fat replacement (e.g., +1.7% to +2.1% FF annually) routinely occurs before functional motor tests show measurable decline, providing early visual and quantitative proof of subclinical progression.
Physiologic Respiratory Weakness (Positional Spirometry & Pressures)
- Diaphragmatic Masking in Upright Spirometry: Standard upright Forced Vital Capacity (FVC) under-detects diaphragmatic weakness because gravity assists abdominal content displacement during inspiration.
- Positional Spirometry Protocol: Paired upright and supine FVC testing unmasks diaphragmatic impairment by removing gravitational assistance.
- Postural Drop Thresholds: A reduction in FVC of greater than 10% when moving from upright to supine is abnormal, whereas a drop of 25% or greater indicates marked diaphragmatic weakness.
- Respiratory Muscle Pressure Metrics: Maximal Inspiratory Pressure (MIP), Maximal Expiratory Pressure (MEP), and Sniff Nasal Inspiratory Pressure (SNIP) directly evaluate respiratory muscle force. Due to the non-linear relationship between lung volume and strength, pressure metrics drop significantly before major falls in FVC become evident.
Biochemical Markers of Disease Activity
- Creatine Kinase (CK) Unreliability: Serum CK is non-specific, subject to wide fluctuations, and often remains flat or decreases as degenerate muscle is replaced by adipose tissue. It is a poor meter for tracking progression.
- Urinary Glucose Tetrasaccharide (uGlc4): Creatinine-normalized uGlc4 reflects muscle glycogen accumulation. A upward trend from a patient's post-treatment nadir provides an objective biochemical signal of accumulating glycogen burden and active disease.
Early Functional Reserve & Power Loss
- Timed Power Tests vs. Endurance: Serial timed tests—such as the Timed Up-and-Go (TUG), 4-stair climb, and 10-meter gait speed—stress muscle power and functional reserve. Small, concordant worsening across multiple timed tests reveals functional loss missed by the 6MWT.
- Patient-Reported Outcomes (PROs): Validated instruments like the Fatigue Severity Scale (FSS) and the Rasch-built Pompe-specific Activity scale (R-PAct) quantify subtle changes in fatigue and participation. Rising fatigue scores and surrendered daily activities (e.g., stopping cycling or taking mandatory naps) signal subclinical decline before clinic strength tests fail.
3. Action Protocol for Confirmed Subclinical Progression
When multimodal monitoring indicates subclinical decline, clinicians should follow a four-step evaluation sequence:
- Confirm: Verify that the observed change is real by repeating the test using standardized protocols to clear the noise floor of visit-to-visit measurement variability.
- Explain: Exclude non-disease contributors, including intercurrent medical conditions, physical deconditioning, sub-optimal treatment adherence, primary sleep disorders, or technical testing errors.
- Integrate: Synthesize findings across all five domains; concordant, confirmed deterioration across multiple complementary measures confirms true subclinical progression.
- Act: Advance management along specific clinical pathways:
- Respiratory Drop / Nocturnal Symptoms: Order overnight oximetry/capnography and initiate non-invasive ventilation (NIV) for confirmed nocturnal hypoventilation.
- Multidomain Progression: Refer to a multidisciplinary team (MDT) to evaluate disease-modifying therapy options against established criteria and update management goals.
4. High-Risk Surveillance Cadence
| Domain | Assessment Tools | Monitoring Frequency |
|---|---|---|
| Motor & Functional | 6MWT, Timed Function Tests (TUG, 4-stair climb, gait speed), Handheld Dynamometry | Every 6–12 months |
| Respiratory | Upright and Supine FVC, MIP/MEP or SNIP | Every 6–12 months (shortened to every 3–6 months if respiratory weakness declared) |
| Sleep / Ventilation | Overnight Oximetry / Capnography | As indicated by nocturnal symptoms or falling respiratory metrics |
| Structural | Quantitative Muscle MRI (Dixon Fat Fraction) | Every 1–3 years |
| Biochemical | Urinary Glc4 (creatinine-normalized, trended from nadir), Serum CK | Every 6–12 months |
| Patient-Reported | FSS, R-PAct, Structured query of surrendered daily activities | Every clinic visit |
Content is accurate as of the date of release